This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

4tt2

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 10:54, 15 March 2023

Crystal structure of ATAD2A bromodomain complexed with H4(1-20)K5Ac peptide

Structural highlights

4tt2 is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

ATAD2_HUMAN May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells.^[1]

Publication Abstract from PubMed

Preventing histone recognition by bromodomains emerges as an attractive therapeutic approach in cancer. Overexpression of ATAD2A in cancer cells is associated with poor prognosis making the bromodomain of ATAD2A a promising epigenetic therapeutic target. In the development of an in vitro assay and identification of small molecule ligands, we conducted structure-guided studies which revealed a conformationally flexible ATAD2A bromodomain. Structural studies on apo-, peptide and small molecule-ATAD2A complexes (by co-crystalization) revealed the bromodomain adopts a "closed", histone-compatible conformation, and a more "open" ligand-compatible conformation of the binding-site respectively. An unexpected conformational change of the conserved asparagine residue plays an important role in driving the peptide-binding conformation remodelling. We also identified dimethylisoxazole-containing ligands as ATAD2A binders which aided in the validation of the in vitro screen and in the analysis of these conformational studies.

Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2A.,Poncet-Montange G, Zhan Y, Bardenhagen JP, Petrocchi A, Leo E, Shi X, Lee Iv GR, Leonard PG, Geck Do MK, Cardozo MG, Andersen JN, Palmer WS, Jones P, Ladbury JE Biochem J. 2014 Dec 8. PMID:25486442^[2]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18067-72. Epub 2007 Nov 12. PMID:17998543 doi:http://dx.doi.org/10.1073/pnas.0705814104
↑ Poncet-Montange G, Zhan Y, Bardenhagen JP, Petrocchi A, Leo E, Shi X, Lee Iv GR, Leonard PG, Geck Do MK, Cardozo MG, Andersen JN, Palmer WS, Jones P, Ladbury JE. Observed bromodomain flexibility reveals histone peptide- and small molecule ligand-compatible forms of ATAD2A. Biochem J. 2014 Dec 8. PMID:25486442 doi:http://dx.doi.org/10.1042/BJ20140933

1 Structural highlights
2 Function
3 Publication Abstract from PubMed
4 See Also
5 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4tt2"

@@ Line 1: / Line 1: @@
 ==Crystal structure of ATAD2A bromodomain complexed with H4(1-20)K5Ac peptide==
-<StructureSection load='4tt2' size='340' side='right' caption='[[4tt2]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
+<StructureSection load='4tt2' size='340' side='right'caption='[[4tt2]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[4tt2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TT2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4TT2 FirstGlance]. <br>
+<table><tr><td colspan='2'>[[4tt2]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4TT2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4TT2 FirstGlance]. <br>
-</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ALY:N(6)-ACETYLLYSINE'>ALY</scene></td></tr>
+</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ALY:N(6)-ACETYLLYSINE'>ALY</scene></td></tr>
-<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4tt4|4tt4]], [[4tt6|4tt6]], [[4tte|4tte]], [[4tu4|4tu4]], [[4tu6|4tu6]]</td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4tt2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tt2 OCA], [https://pdbe.org/4tt2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4tt2 RCSB], [https://www.ebi.ac.uk/pdbsum/4tt2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4tt2 ProSAT]</span></td></tr>
-<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">ATAD2, L16, PRO2000 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
-<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Adenosinetriphosphatase Adenosinetriphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.3 3.6.1.3] </span></td></tr>
-<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tt2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tt2 OCA], [http://pdbe.org/4tt2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tt2 RCSB], [http://www.ebi.ac.uk/pdbsum/4tt2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tt2 ProSAT]</span></td></tr>
 </table>
 == Function ==
-[[http://www.uniprot.org/uniprot/ATAD2_HUMAN ATAD2_HUMAN]] May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells.<ref>PMID:17998543</ref>
+[https://www.uniprot.org/uniprot/ATAD2_HUMAN ATAD2_HUMAN] May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells.<ref>PMID:17998543</ref>
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 21: / Line 18: @@
 </div>
 <div class="pdbe-citations 4tt2" style="background-color:#fffaf0;"></div>
+==See Also==
+*[[ATPase family AAA domain-containing protein|ATPase family AAA domain-containing protein]]
 == References ==
 <references/>
 __TOC__
 </StructureSection>
-[[Category: Adenosinetriphosphatase]]
+[[Category: Homo sapiens]]
-[[Category: Human]]
+[[Category: Large Structures]]
-[[Category: Andersen, J]]
+[[Category: Andersen J]]
-[[Category: Bardenhagen, J]]
+[[Category: Bardenhagen J]]
-[[Category: Cardozo, M]]
+[[Category: Cardozo M]]
-[[Category: Do, M Geck]]
+[[Category: Geck Do M]]
-[[Category: Jones, P]]
+[[Category: Jones P]]
-[[Category: Ladbury, J]]
+[[Category: Ladbury J]]
-[[Category: Lee, G]]
+[[Category: Lee G]]
-[[Category: Leo, E]]
+[[Category: Leo E]]
-[[Category: Leonard, P]]
+[[Category: Leonard P]]
-[[Category: Palmer, W]]
+[[Category: Palmer W]]
-[[Category: Petrocchi, A]]
+[[Category: Petrocchi A]]
-[[Category: Poncet-Montange, G]]
+[[Category: Poncet-Montange G]]
-[[Category: Shi, X]]
+[[Category: Shi X]]
-[[Category: Zhan, Y]]
+[[Category: Zhan Y]]
-[[Category: Bromodomain-acetylated histone complex]]
-[[Category: Gene regulation]]

4tt2

From Proteopedia

Revision as of 10:54, 15 March 2023

Crystal structure of ATAD2A bromodomain complexed with H4(1-20)K5Ac peptide

Structural highlights

Function

Publication Abstract from PubMed

See Also

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox